Asia-Pacific (APAC) Melanoma Scanner Market Size, Trends, Share, Industry Analysis, Demand, Growth Drivers, Opportunity Assessment, Regional Outlook & Forecast 2017-2025

Asia Pacific Melanoma Scanner Market 

Market Overview

Melanoma is a cancer that initiates in the melanocytes and also refers to as malignant melanoma and cutaneous melanoma. Melanoma cells make melanin, therefore melanoma tumors are usually brown or black while few melanomas do not make melanin and can appear pink, tan, or even white. The annual mortality rate per 100,000 people from malignant skin melanoma in India has decreased by 30.0% since 1990, an average of 1.3% a year. In Taiwan, Acral lentiginous melanoma comprises 58% of cutaneous melanoma. In Asia, Israel, Georgia, Kazakhstan, Armenia, Turkmenistan, Azerbaijan, Turkey, Japan, South Korea, Maldives, Taiwan, Lebanon, Singapore, Thailand, Myanmar, Malaysia, India, Cambodia, Philippines, North Korea, China, Indonesia, Iran, etc are the major target for Malignant Skin Melanoma.

Goldstein Research analyst forecast the melanoma scanner market size is set to reach USD 179.1 million by 2025, at a CAGR of 7.12% over the forecast years. Increasing prevalence of melanoma skin cancer and enhancement of healthcare sector tends to drive the APAC melanoma scanner market.

Intended Audience

• Melanoma Scanner Suppliers
• Melanoma Scanner Manufacturers
• Research and Development (R&D) Companies
• Medical Research Laboratories
• Diagnostic Centers
• Business consultancies
• Venture capitalists
• Public and private health agencies

Covered In This Asia Pacific Melanoma Scanner Market Report

The report covers the present ground scenario and the future growth prospects of the melanoma scanner market for 2017-2025 along with the data of shipments of melanoma scanner in Asia Pacific. We calculated the market size and revenue share on the basis of revenue generated from major players across the globe. The melanoma scanner market is forecasted on the basis of revenue analysis, product benchmarking and strategic developments of key market players. The report also includes micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Asia Pacific Melanoma Scanner Market Segmentation

By Product Type

• Standalone Melanoma Scanner
• Handheld Melanoma Scanner

By Skin Melanoma

• Superficial Spreading Melanoma
• Nodular Melanoma
• Lentigo Maligna
• Acral Lentiginous Melanoma

By End User

• Hospitals
• Skin Clinics
• Cancer Research Organizations

Based on Geography

• China Melanoma Scanner Market {Market Share (%), Market Size(USD Billion)}
• India Melanoma Scanner Market {Market Share (%), Market Size(USD Billion)}
• Japan Melanoma Scanner Market{Market Share (%), Market Size(USD Billion)}
• Singapore Melanoma Scanner Market{Market Share (%), Market Size(USD Billion)}
• South Korea Melanoma Scanner Market {Market Share (%), Market Size(USD Billion)}
• Thailand Melanoma Scanner Market {Market Share (%), Market Size(USD Billion)}
• Malaysia Melanoma Scanner Market {Market Share (%), Market Size(USD Billion)}
• Indonesia Melanoma Scanner Market {Market Share (%), Market Size(USD Billion)}
• Australia Melanoma Scanner Market {Market Share (%), Market Size(USD Billion)}
• New Zealand Melanoma Scanner Market {Market Share (%), Market Size(USD Billion)}
• Rest of Asia Melanoma Scanner Market {Market Share (%), Market Size(USD Billion)}

Based on product type, handheld melanoma scanner dominated the Asia Pacific melanoma scanner market and accounted for the market share of 63.1% in 2017 of total melanoma scanner market attributed to hand-held device are easy to learn and use, and it rapidly provides accurate images of the melanin, blood, and collagen below the mole or lesion. On the basis of the end user, skin clinics tends to be the fastest growing segment due to the awareness and increasing prevalence of skin melanomas.

Asia Pacific Melanoma Scanner Market - Trends Analysis, Major Players & Challenges

Asia Pacific Melanoma Scanner Market Outlook 2017-2025, has been prepared based on an in-depth market analysis from industry experts. The report covers the competitive landscape and current position of major players in the Asia Pacific Melanoma Scanner market. The report also includes porter’s five force model, SWOT analysis, company profiling, business strategies of market players and their business models. Asia Pacific Melanoma Scanner market report also recognizes value chain analysis to understand the cost differentiation to provide competitive advantage to the existing and new entry players.

Our Asia Pacific melanoma scanner market report comprises of the following companies as the key players: Strata Skin Sciences, Verisante, MedX Health, Abbott Laboratory, Medtronic, Siemens AG, Baxter International Inc., Agilent Technology, Roche, AstraZeneca.

According to our Asia Pacific market study on the basis of extensive primary and secondary research: “One trend is the advent of the specially adapted programmes which are responsible to increase awareness of the different clinical presentation of melanoma in Asia and to encourage examination of the palms and soles in order to reduce the delay in diagnosis.”

According to the report, major driving factor is the growing skin cancer therapeutics market with increasing prevalence of melanoma skin cancer cases. In APAC region, notorious aggressiveness of melanoma is associated with its metastatic propensity, which can occur even from shallow primary tumors. According to the clinical evidence, the survival rate in patients with multiple site of metastasis disease is less than 5% and for patients with malignant melanoma, surgery is the most essential treatment other than medical measures such as chemotherapy and cytokine therapy.   

Further, the report states the biggest challenge is unavailability and awareness of melanoma scanner and the trained medical personnel in some of the emerging economies like China, India, Taiwan, Malaysia, etc coupled with high treatment cost of melanoma skin cancer is restraining the growth of melanoma scanner market.  

Based on geography, cutaneous melanoma is rare in Asia while outcome of melanoma is not well described in Southeast Asia. Acral lentiginous melanoma (ALM) was the most common subtype of melanoma in Singapore (50%) and in comparison to Caucasians, there was a trend towards Asian patients being older, having a higher proportion of ALM and a longer delay to diagnosis. Healthcare infrastructure in China, Japan, India, Taiwan, Indonesia, Singapore, Australia, Korea, etc are spending to shape up the medical facilities, which are primarily driven by consumers’ rapidly increasing incomes and the government’s public health care reforms. For instance, China’s annual expenditure is projected to grow at an average rate of 11.72% a year in 2014-2018, reaching USD 856 billion by 2018.

 The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

For a full detailed overview, send us the sample request.

Key questions answered in this Melanoma Scanner Market Report

• What is the total market size by 2025 and what would be the expected growth rate of market?
• What is the revenue of total market in 2016-17 and what would be the expected demand over the forecast period?
• What are the key market trends?
• What are the factors which are driving this market?
• What are the major barriers to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities for the existing and entry level players?
• What are the recent developments and business strategy of the key players?

We can provide two hour complimentary interaction with our analyst after the purchase of this market report. Details are imparted within the report.